Mohammad Hirmand, EVP & Chief Medical Officer at Turning Point Therapeutics, Inc. (TPTX), sold 669 shares at $36.30 ($24K) on 2022-02-09, disclosed to the SEC on 2022-02-11.
Open-market sale of $24k TPTX by EVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MDVN | SELL | 2015-12-04 | $47K | — | Filing → |
| MDVN | SELL | 2015-11-12 | $10K | — | Filing → |